Marulicev trg, Croatia

Marija Cakara


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marija Cakara: Innovator in Pharmaceutical Purification

Introduction

Marija Cakara is a notable inventor based in Marulicev trg, Croatia. She has made significant contributions to the field of pharmaceuticals, particularly in the purification of oxytetracycline. Her innovative approach has led to advancements in the production of this important antibiotic.

Latest Patents

Marija Cakara holds a patent for a process and intermediate for the purification of oxytetracycline. This invention relates to a new method for obtaining completely pure oxytetracycline, free from any acetyldecarboxamidooxytetracycline. The process involves suspending oxytetracycline hydrochloride or oxytetracycline dihydrate in glacial acetic acid, followed by the addition of an equimolar quantity of hydrogen chloride. The stirring continues for five hours, resulting in the formation of an oxytetracycline hydrochloride acetate precipitate, which is then filtered, washed, and dried under reduced pressure. This new compound serves as an intermediate in the purification process.

Career Highlights

Marija Cakara is associated with Pliva, Inc., a prominent pharmaceutical company. Her work has been instrumental in enhancing the quality and efficacy of pharmaceutical products. With her expertise, she has contributed to the development of innovative solutions in the industry.

Collaborations

Marija collaborates with Bozidar Suskovic, who is also a key figure in her research endeavors. Their partnership has fostered a productive environment for innovation and development in pharmaceutical sciences.

Conclusion

Marija Cakara's contributions to the field of pharmaceutical purification exemplify her dedication to innovation. Her patent for the purification of oxytetracycline showcases her ability to address complex challenges in the industry. Through her work at Pliva, Inc., she continues to make a significant impact on the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…